tiprankstipranks
Trending News
More News >
AegirBio AB (DE:52Q)
FRANKFURT:52Q
Germany Market

AegirBio AB (52Q) Income Statement

Compare
0 Followers

AegirBio AB Income Statement

Last quarter (Q2 2022), AegirBio AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, AegirBio AB's net income was $-17.27M. See AegirBio AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ 5.51M$ 0.00$ ―
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―
EBITDA
$ -88.44M$ -10.31M$ 0.00
Operating Income
$ -81.52M$ -10.35M$ 0.00
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -92.33M$ -10.35M$ -62.00
Per Share Metrics
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

AegirBio AB Earnings and Revenue History